Ovarian cancer survival: Steady improvement, despite rhetoric to the contrary

MarkmanM.

首页> 外文期刊>Current oncology reports. >Ovarian cancer survival: Steady improvement, despite rhetoric to the contrary

【24h】

Ovarian cancer survival: Steady improvement, despite rhetoric to the contrary

机译：卵巢癌生存率：尽管有相反的说法，但仍稳定增长

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The words convey a sililar message and they sound authoritative:Over the past "several decades there has been limited,if any,improvement in outcome for women diagnosed with advanced epithelial ovarian cancer

机译：这些词传达了一种嘲讽的信息，听起来很权威：在过去的“几十年中，诊断为晚期上皮性卵巢癌的妇女的预后改善有限（如果有的话）

著录项

来源
《Current oncology reports.》 |2013年第5期|共3页
作者
MarkmanM.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Ovarian cancer survival: Steady improvement, despite rhetoric to the contrary [J] . MarkmanM. Current oncology reports. . 2013,第5期

机译：卵巢癌生存率：尽管有相反的说法，但仍稳定增长
2. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control. [J] . Luke C, Tracey E, Stapleton A, Internal medicine journal . 2010,第5期

机译：探索膀胱癌发病率，死亡率和存活率的相反趋势：对研究和癌症控制的意义。
3. No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands [J] . M. Timmermans, G.S. Sonke, K.K. Van de Vijver, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：对上皮性卵巢癌患者的长期存活没有改善：1989年至2014年在荷兰的基于人口的研究
4. Computer extracted features related to the spatialarrangement of tumor-infiltrating lymphocytes predict overall survival in epithelial ovarian cancer receiving adjuvant chemotherapy [C] . Sepideh Azarianpour, Germán Corredor, Kaustav Bera, Conference on Medical Imaging: Digital Pathology . 2020

机译：计算机提取与空间相关的功能肿瘤浸润淋巴细胞的安排预测上皮性卵巢癌接受佐剂化疗的整体存活
5. Studies on the Survival of Ovarian Cancer Cells Following Treatment with Beta-Adrenergic Receptor Agonists and Antagonists [D] . Horan, Noah Patrick. 2020

机译：用β-肾上腺素能受体激动剂和拮抗剂治疗卵巢癌细胞存活的研究
6. Retrospective Analysis of Survival Improvement by Molecular Biomarker-Based Personalized Chemotherapy for Recurrent Ovarian Cancer [O] . Youngchul Kim, Saketh R. Guntupalli, Sun J. Lee, 2010

机译：回顾性分析基于分子生物学标志物的个性化化疗对复发性卵巢癌患者生存率的改善
7. Improved survival time: What can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? [O] . Lan Huang, Kathleen A Cronin, Karen A. Johnson, 2008

机译：提高生存时间：生存治愈模型的内容可以告诉我们，晚期结直肠癌，卵巢和睾丸癌的基于人群的生存改善？

Ovarian cancer survival: Steady improvement, despite rhetoric to the contrary

摘要

著录项

相似文献

相关主题

期刊订阅